Results 71 to 80 of about 7,517 (258)

Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017–2019

Journal of Dermatological Treatment
Background Response rates of approved systemic therapies for cutaneous T-cell lymphoma (CTCL) hover near 30%, suggesting unmet need. This study describes real-world treatment patterns and response rates of extracorporeal photopheresis (ECP) in CTCL ...
Michael Girardi, Kacie Carlson, Xingyue Huang, Shelby L. Corman, Patrick Edmundson, Jordana Schmier, Hrishikesh P. Kale, Rutika Raina, Francine Foss   +8 more
doaj   +1 more source

Extracorporeal Photopheresis—An Overview

Frontiers in Medicine, 2018
Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of cutaneous T-cell lymphoma (CTCL) in 1988.
Ara Cho, Christian Jantschitsch, Robert Knobler   +2 more
doaj   +1 more source

Apoptotic cell-based therapies against transplant rejection: role of recipient’s dendritic cells [PDF]

, 2010
One of the ultimate goals in transplantation is to develop novel therapeutic methods for induction of donor-specific tolerance to reduce the side effects caused by the generalized immunosuppression associated to the currently used pharmacologic regimens.
A Ariel, A Krispin, A Lamioni, A Lamioni, A Maeda, A Maeda, A Ross, Adrian E. Morelli, Adriana T. Larregina, AE Morelli, AE Morelli, AE Morelli, AJ Adler, AT Larregina, B Sauter, BC Oh, BC Speich, BC Urban, C Kurts, C Scheinecker, C-Q Xia, CA Williams, CG Persijn, CH Qiu, D Hawiger, DC Brennan, DL Xu, E Gatza, E Sun, EM Behrens, EM Behrens, F Kleinclauss, F Meloni, F Wermeling, F-P Huang, G Castellano, G Opelz, G Ren, HT Greinix, HW Lim, I Baumann, I Di Biaso, I Verbovetski, J Dalgaard, J Ludvigsson, JC Madsen, JF George, JH Horina, JMJ Bhandari, K Inaba, K Kishimoto, K Liu, K Morimoto, K Nagata, K Stadler, KR Suchin, KS Ravichandran, L Bonifaz, L Truedsson, L Urbani, L-P Erwig, LI Craciun, LM Stuart, M Albert, M Botto, M Carvalho Bittencourt De, M Cvetanovic, M Di Renzo, M Gerner, M Gray, M Hivelin, M Niimi, M Nouri-Shirazi, M Perez, M Skoberne, M Takahashi, M-LN Huynh, MA Stark, MA Wallet, MB Parr, MC Bickerstaff, ME Flowers, ML Albert, ML Albert, ML Barr, ML Wood, MR Costanzo-Nordin, MR Costanzo-Nordin, MR Ehrenstein, N Luckashenak, O Salvatierra, P Gurung, P Pepino, P Saas, P Sen, PL Cohen, PR Taylor, R Hanayama, R Kushwah, R Rizzo, RE Voll, RM Steinman, RM Steinman, RM Steinman, RS Scott, S Gallucci, S Kim, S Nagata, S Perruche, S Perruche, S Schmitt, SA Quezada, SJ Divito, T Iyoda, T Nakano, TA Ferguson, U Holtick, U Johansson, V Rao, VA Fadok, VA Patel, W Chen, WK Ip, WT Newton, X Chen, Y Gao, Y Mishima, Y Miyake, Y Shoshan, Z Chen, Z Wang, Z Wang   +131 more
core   +2 more sources

Outcome of extracorporeal photopheresis in mycosis fungoides patients is not predicted by quotients of systemic immune‐inflammatory biomarkers

Journal of clinical apheresis, 2022
Systemic immune‐inflammatory biomarkers (SIIBs) have not been studied in mycosis fungoides (MF) patients undergoing extracorporeal photopheresis (ECP).
T. Gambichler, Jan Späth, Shayda Said, C. Scheel, L. Susok, R. Stranzenbach   +5 more
semanticscholar   +1 more source

Management challenge of a rare concomitant platelet glycoprotein IV/CD36 and IIb/IIIa deficiencies: Case illustration

Transfusion, Volume 65, Issue 4, Page 767-772, April 2025.
Abstract Introduction/Background Platelet membrane glycoproteins (GPs) serve several functions, the most significant of which is their role in primary hemostasis. Among these, GP IIb/IIIa is the primary fibrinogen receptor and is essential for platelet aggregation.
Tro Sekayan, Elizabeth S. Allen, Patricia Kopko, Laura D. Stephens, Mitchell Zhao, Brian R. Curtis, Mia J. Sullivan, Valerie Trapp‐Stamborski, Annette von Drygalski   +8 more
wiley   +1 more source

Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial

Frontiers in Immunology
IntroductionExtracorporeal photopheresis (ECP) is a viable treatment that slows the progression of chronic lung allograft dysfunction. Despite its immunoregulatory potential, data on extracorporeal photopheresis as an induction therapy remain rather ...
Ilaria Righi, Claudio Fenizia, Daria Trabattoni, Mario Nosotti, Mario Nosotti, Giacomo Grisorio, Claudia Vanetti, Claudia Vanetti, Sonia di Tella, Cristina Mocellin, Norma Fantini, Daniele Prati, Letizia Corinna Morlacchi, Valeria Rossetti, Francesco Blasi, Francesco Blasi, Mario Clerici, Mario Clerici, Lorenzo Paolo Rosso, Lorenzo Paolo Rosso   +19 more
doaj   +1 more source

Extracorporeal photopheresis in solid organ transplantation

Alʹmanah Kliničeskoj Mediciny, 2020
Despite the use of up-to-date immunosuppressive agents, graft rejection episodes are quite common and pose a serious threat to thousands of solid organ recipients.
A. V. Kildyushevsky, Ya. G. Moysyuk, A. V. Molochkov, T. A. Mitina, A. P. Faenko   +4 more
doaj   +1 more source

Optoelectronic Biomedical Systems for Noninvasive Treatment and Control with Informated Support in Solutions [PDF]

, 2015
The chapter presents the development of an optical-electronic system with informated support in doctor solutions for its application in hematology, otorhinolaryngology, and dermatology.
Hryhoriy, Barylo, Ivanna, Makara, Mariya, Ivakh, Oleksandr, Kozhukhar, Volodymyr, Virt, Zenon, Gotra   +5 more
core   +2 more sources

Extracorporeal photopheresis for the treatment of chronic graft versus host disease

Hematology, 2022
Objectives Chronic graft versus host disease (chronic GVHD) still remains the leading cause of late morbidity and mortality for allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients.
E. Kansu, D. Ward, Amber P. Sanchez, R. Cunard, M. Hayran, B. Huseyin, Majella Vaughan, G. Ku, P. Curtin, C. Mulroney, C. Costello, J. Castro, M. Wieduwilt, S. Corringham, Anita Ihasz-Davis, C. Nelson, E. Ball   +16 more
semanticscholar   +1 more source

Implementation of a novel hybrid cord blood banking model within a private‐public‐partnership

Transfusion, Volume 65, Issue 4, Page 725-731, April 2025.
Abstract Background Umbilical cord blood (UCB) stem cells can be collected at birth, cryopreserved, and used for transplantation in hematopoietic diseases. Typically, these stem cells are stored in public banks for allogeneic use or in private depositories for potential future utilization by the family.
Jessica Laue, L. Mariotta, M. Fluri, D. Castelli, O. Kürsteiner, G. Nicoloso, A. Etter, D. Surbek   +7 more
wiley   +1 more source